FDA-approved biosimilars are alternatives to reference biologics – much like generic drugs – providing more affordable treatment options for patients who need biologic medicines to manage their conditions.
Biologic medicines involve complex research and development. They are often expensive. Learn about alternatives to brand-name biologic medicines in this infographic about biosimilars.
This FDA-produced infographic is for patients in the United States who want to learn more about biosimilars.
This infographic from the Biosimilars Council details how a biosimilar moves through the approval process to reach patients.
This infographic introduces key concepts related to biosimilars, including an introduction to biologics, what “highly similar” means, what “no clinically meaningful differences” means and how biosimilars are evaluated and monitored.
Learn more about the development, review and approval processes for biologics.
Are you or a loved one taking a biosimilar medication?
Sign up for our Introduction to Biosimilars email series and get a more in-depth look into these treatments.
